Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

The generation of animals lacking SMAD proteins, which transduce signals from transforming growth factor-β (TGF-β), has made it possible to explore the contribution of the SMAD proteins to TGF-β activity in vivo. Here we report that, in contrast to predictions made on the basis of the ability of exogenous TGF-β to improve wound healing, Smad3-null (Smad3ex8/ex8) mice paradoxically show accelerated cutaneous wound healing compared with wild-type mice, characterized by an increased rate of re-epithelialization and significantly reduced local infiltration of monocytes. Smad3ex8/ex8 keratinocytes show altered patterns of growth and migration, and Smad3ex8/ex8 monocytes exhibit a selectively blunted chemotactic response to TGF-β. These data are, to our knowledge, the first to implicate Smad3 in specific pathways of tissue repair and in the modulation of keratinocyte and monocyte function in vivo.

[1]  P. Howe,et al.  TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.

[2]  K. Miyazono,et al.  Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.

[3]  A. Roberts,et al.  Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.

[4]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[5]  G. Feldman,et al.  STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. , 1997, Blood.

[6]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Bruns,et al.  On the mechanism of skin wound "contraction": a granulation tissue "knockout" with a normal phenotype. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. J. Chen,et al.  Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. , 1999, The Journal of investigative dermatology.

[9]  S. Wahl,et al.  Transforming growth factor β: a matter of life and death , 1994 .

[10]  D. Kamp,et al.  Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. , 1988, Biochemical and biophysical research communications.

[11]  A. Roberts,et al.  Transforming growth factor‐β: activity and efficacy in animal models of wound healing , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[12]  R. Weinberg,et al.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Deng,et al.  Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Massagué,et al.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.

[15]  S. O'Kane,et al.  Transforming growth factor βs and wound healing , 1997 .

[16]  Y. Yatabe,et al.  Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells , 1998, Oncogene.

[17]  R. Derynck,et al.  Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.

[18]  P. Hebda,et al.  Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. , 1988, The Journal of investigative dermatology.

[19]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[20]  M. Sporn,et al.  Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture , 1989 .

[21]  X. F. Wang,et al.  Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction , 1999, Molecular and Cellular Biology.

[22]  A. Roberts,et al.  SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Massagué,et al.  Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. , 1999, Nature.

[24]  A. Giannetti,et al.  Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing , 1995, The Journal of cell biology.

[25]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.

[26]  J. Gauthier,et al.  A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3 , 1999, Oncogene.

[27]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[28]  A. Roberts,et al.  Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. , 1998, Genes & development.

[29]  M. Ferguson,et al.  Transforming growth factor beta s and wound healing. , 1997, The international journal of biochemistry & cell biology.

[30]  S. Yuspa,et al.  Isolation and utilization of epidermal keratinocytes for oncogene research. , 1995, Methods in enzymology.

[31]  K. Irie,et al.  The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. , 1998, Nature.

[32]  S. Wahl,et al.  Transforming growth factor beta: a matter of life and death. , 1994, Journal of leukocyte biology.

[33]  S. Wahl,et al.  Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Tarnuzzer,et al.  Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels , 1997, Nature Medicine.

[35]  M. Sporn,et al.  Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. , 1989, Journal of cellular physiology.

[36]  J. Graff,et al.  Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.

[37]  Thomas A. Mustoe, MD, FACS,et al.  Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. , 1991, The Journal of clinical investigation.

[38]  Thomas A. Mustoe, MD, FACS,et al.  Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.